XT
OTLK icon

XTX Topco’s Outlook Therapeutics OTLK Stock Holding History

XTX Topco’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.9K Buy
52,994
+22,770
+75% +$9.84K ﹤0.01% 3671
2025
Q4 		$47.8K Buy
30,224
+19,214
+175% +$30.7K ﹤0.01% 2844
2025
Q3 		$11.7K Sell
11,010
-72,140
-87% -$125K ﹤0.01% 2423
2025
Q2 		$133K Buy
+83,150
New +$133K 0.01% 1818
2025
Q1 		– Sell
-10,244
Closed -$19.4K – 2915
2024
Q4 		$19.4K Sell
10,244
-27,084
-73% -$111K ﹤0.01% 2047
2024
Q3 		$199K Buy
+37,328
New +$273K 0.01% 1445
2022
Q2 		– Sell
-2,105
Closed -$75K – 1037
2022
Q1 		$75K Buy
+2,105
New +$65.7K 0.03% 551
2021
Q3 		– Sell
-544
Closed -$27K – 963
2021
Q2 		$27K Buy
+544
New +$25.2K 0.01% 756

Other funds holding OTLK

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $126M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $693M AUM 31.93% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

XTX Topco's OTLK Position: Q1 2026 in Review

XTX Topco increased its Outlook Therapeutics (OTLK) stake by 75% in Q1 2026, buying an estimated $9.84K and bringing the position to 52,994 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3671.

XTX Topco first reported a position in OTLK in Q2 2021 and has held it in 8 quarters since. The position peaked at $199K in Q3 2024. 54 funds tracked by Wall St. Rank hold OTLK as of Q1 2026.

  • XTX Topco held 52,994 shares of Outlook Therapeutics worth $10.9K as of Q1 2026.
  • XTX Topco bought 22,770 Outlook Therapeutics shares in Q1 2026, an estimated $9.84K.
  • Outlook Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3671 holding.
  • XTX Topco first reported a position in Outlook Therapeutics in Q2 2021 and has held it in 8 quarters since.
  • XTX Topco's Outlook Therapeutics position peaked at $199K in Q3 2024.
  • 54 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.